The following table shows the list of Horizon 2020 projects developed by "IMMATICS BIOTECHNOLOGIES GMBH". Projects are ordered by starting date.
Click on table headers to rearrange data.
# | acronym | programme | role | EC contrib. | start | views |
---|---|---|---|---|---|---|
1 | AML-VACCiN | H2020-EU.3.1.3. | participant | 1˙300˙650.00 | 2016-01-01 | 818 |
totale | 1˙300˙650.00 |
This organization collaborated with partners in 5 countries.
Within the project AML-VACCiN this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
coordinator | NL | VUmc | STICHTING VUMC (REC) |
participant | NL | Accelovance BV | LINICAL ACCELOVANCE EUROPE BV (PRC) |
participant | NL | DCPrime | DCPRIME BV (PRC) |
participant | NL | VU | STICHTING VU (HES) |
participant | NO | HUS | HELSE BERGEN HF*HAUKELAND UNIVERSITY HOSPITAL (HES) |
participant | DE | UMC-Mainz | UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAET MAINZ (HES) |
participant | DE | EUFETS | BIONTECH INNOVATIVE MANUFACTURING SERVICES GMBH (PRC) |
participant | DE | UKB | UNIVERSITATSKLINIKUM BONN (HES) |
participant | DE | TUD | TECHNISCHE UNIVERSITAET DRESDEN (HES) |
participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
participant | NO | UiB | UNIVERSITETET I BERGEN (HES) |
participant | SE | SNIC-UU | UPPSALA UNIVERSITET (HES) |
participant | FI | UH | HELSINGIN YLIOPISTO (HES) |